| SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma. | SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma.
Zhang J, Duan B, Li F, Jing X, Li R, Cai S, Cao L, Jiang Q, Zhou J, Zhou J, Qin Y, Wang X, Tong D, Huang C., Free PMC Article | 10/29/2024 |
| Epigenetic mechanism of SET7/9-mediated histone methylation modification in high glucose-induced ferroptosis in retinal pigment epithelial cells. | Epigenetic mechanism of SET7/9-mediated histone methylation modification in high glucose-induced ferroptosis in retinal pigment epithelial cells.
Du Y, Jiang X, Zhang Y, Ying J, Yi Q. | 09/4/2024 |
| ZKSCAN5 activates LAPTM5 expression by recruiting SETD7 to promote metastasis in pancreatic ductal adenocarcinoma. | ZKSCAN5 activates LAPTM5 expression by recruiting SETD7 to promote metastasis in pancreatic ductal adenocarcinoma.
Yang Y, Xie W, Qiao X, Yang J, Yao D, Zhu D. | 07/26/2024 |
| Combined SET7/9 and CDK4 inhibition act synergistically against osteosarcoma. | Combined SET7/9 and CDK4 inhibition act synergistically against osteosarcoma.
Shi Y, Wang Z, Shao Y, Guang Q, Zhang J, Liu B, Wu C, Wang Y, Sui P. | 04/12/2024 |
| Methyltransferase Set7/9 controls PARP1 expression and regulates cisplatin response of breast cancer cells. | Methyltransferase Set7/9 controls PARP1 expression and regulates cisplatin response of breast cancer cells.
Myadelets D, Parfenyev S, Vasileva J, Shuvalov O, Petukhov A, Fedorova O, Barlev N, Daks A. | 01/4/2024 |
| SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A. | SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
Gu R, Kim TD, Song H, Sui Y, Shin S, Oh S, Janknecht R., Free PMC Article | 11/10/2023 |
| Methylation of KRAS by SETD7 promotes KRAS degradation in non-small cell lung cancer. | Methylation of KRAS by SETD7 promotes KRAS degradation in non-small cell lung cancer.
Chiang CY, Fan S, Zheng H, Guo W, Zheng Z, Sun Y, Zhong C, Zeng J, Li S, Zhang M, Xiao T, Zheng D. | 10/11/2023 |
| Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade. | Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade.
Lv J, Wu Q, Li K, Bai K, Yu H, Zhuang J, Sun H, Yang H, Yang X, Lu Q., Free PMC Article | 08/16/2023 |
| SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1. | SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.
Wang Z, Petricca J, Liu M, Zhang S, Chen S, Li M, Besschetnova A, Patalano S, Venkataramani K, Siegfried KR, Macoska JA, Han D, Gao S, Vedadi M, Arrowsmith CH, He HH, Cai C., Free PMC Article | 08/9/2023 |
| SET7 methylates the deubiquitinase OTUB1 at Lys [122] to impair its binding to E2 enzyme UBC13 and relieve its suppressive role on ferroptosis. | SET7 methylates the deubiquitinase OTUB1 at Lys (122) to impair its binding to E2 enzyme UBC13 and relieve its suppressive role on ferroptosis.
Deng H, Jia S, Tang J, Rong F, Xu C, Chen X, Wang Z, Zhu C, Sun X, Liao Q, Liu W, Li W, Xiao W, Liu X., Free PMC Article | 05/1/2023 |
| DDB1 regulates the activation-induced apoptosis of T cells via downregulating the expression of histone methyltransferase SETD7. | DDB1 regulates the activation-induced apoptosis of T cells via downregulating the expression of histone methyltransferase SETD7.
Wu R, Wu X, Zou L, Zhou L, Mao Y. | 04/14/2023 |
| [Research Progress of Role and Mechanism of SETD7 in Tumor Occurrence and Progression]. | [Research Progress of Role and Mechanism of SETD7 in Tumor Occurrence
and Progression].
Cao L, Wang M, Xu K., Free PMC Article | 02/22/2023 |
| Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational study. | Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational study.
Ambrosini S, Montecucco F, Kolijn D, Pedicino D, Akhmedov A, Mohammed SA, Herwig M, Gorica E, Szabó PL, Weber L, Russo G, Vinci R, Matter CM, Liuzzo G, Brown PJ, Rossi FMV, Camici GG, Sciarretta S, Beltrami AP, Crea F, Podesser B, Lüscher TF, Kiss A, Ruschitzka F, Hamdani N, Costantino S, Paneni F. | 01/28/2023 |
| The role of SET domain containing lysine methyltransferase 7 in tumorigenesis and development. | The role of SET domain containing lysine methyltransferase 7 in tumorigenesis and development.
Yang S, Wang X, Bai J, Duan B., Free PMC Article | 01/21/2023 |
| Non-histone Methylation of SET7/9 and its Biological Functions. | Non-histone Methylation of SET7/9 and its Biological Functions.
Gao L, Yu W, Song P, Li Q. | 07/2/2022 |
| Melatonin regulates trophoblast pyroptosis, invasion and migration in preeclampsia by inhibiting HtrA1 transcription through the microRNA-520c-3p/SETD7 axis. | Melatonin regulates trophoblast pyroptosis, invasion and migration in preeclampsia by inhibiting HtrA1 transcription through the microRNA-520c-3p/SETD7 axis.
Liu Z, Chen B, Chang J, Feng L, Zhao X. | 05/14/2022 |
| SRF is a nonhistone methylation target of KDM2B and SET7 in the regulation of skeletal muscle differentiation. | SRF is a nonhistone methylation target of KDM2B and SET7 in the regulation of skeletal muscle differentiation.
Kwon DH, Kang JY, Joung H, Kim JY, Jeong A, Min HK, Shin S, Lee YG, Kim YK, Seo SB, Kook H., Free PMC Article | 02/19/2022 |
| lncRNA SNHG6 promotes hepatocellular carcinoma progression by interacting with HNRNPL/PTBP1 to facilitate SETD7/LZTFL1 mRNA destabilization. | lncRNA SNHG6 promotes hepatocellular carcinoma progression by interacting with HNRNPL/PTBP1 to facilitate SETD7/LZTFL1 mRNA destabilization.
Wang H, Ma P, Liu P, Guo D, Liu Z, Zhang Z. | 01/8/2022 |
| Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells. | Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells.
Daks A, Mamontova V, Fedorova O, Petukhov A, Shuvalov O, Parfenyev S, Netsvetay S, Venina A, Kizenko A, Imyanitov E, Barlev N. | 11/22/2021 |
| Methylation of PLK1 by SET7/9 ensures accurate kinetochore-microtubule dynamics. | Methylation of PLK1 by SET7/9 ensures accurate kinetochore-microtubule dynamics.
Yu R, Wu H, Ismail H, Du S, Cao J, Wang J, Ward T, Yang F, Gui P, Ali M, Chu L, Mo F, Wang Q, Chu Y, Zang J, Zhao Y, Ye M, Fang G, Chen PR, Dou Z, Gao X, Wang W, Liu X, Yao X., Free PMC Article | 08/14/2021 |
| SET7/9 promotes H3K4me3 at lncRNA DRAIC promoter to modulate growth and metastasis of glioma. | SET7/9 promotes H3K4me3 at lncRNA DRAIC promoter to modulate growth and metastasis of glioma.
Li C, Feng SY, Chen L. | 07/3/2021 |
| The Set7 Lysine Methyltransferase Regulates Plasticity in Oxidative Phosphorylation Necessary for Trained Immunity Induced by beta-Glucan. | The Set7 Lysine Methyltransferase Regulates Plasticity in Oxidative Phosphorylation Necessary for Trained Immunity Induced by β-Glucan.
Keating ST, Groh L, van der Heijden CDCC, Rodriguez H, Dos Santos JC, Fanucchi S, Okabe J, Kaipananickal H, van Puffelen JH, Helder L, Noz MP, Matzaraki V, Li Y, de Bree LCJ, Koeken VACM, Moorlag SJCFM, Mourits VP, Domínguez-Andrés J, Oosting M, Bulthuis EP, Koopman WJH, Mhlanga M, El-Osta A, Joosten LAB, Netea MG, Riksen NP., Free PMC Article | 05/15/2021 |
| METTL3/YTHDF2 m(6) A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer. | METTL3/YTHDF2 m(6) A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.
Xie H, Li J, Ying Y, Yan H, Jin K, Ma X, He L, Xu X, Liu B, Wang X, Zheng X, Xie L., Free PMC Article | 05/1/2021 |
| Downregulation of SETD7 promotes migration and invasion of lung cancer cells via JAK2/STAT3 pathway. | Downregulation of SETD7 promotes migration and invasion of lung cancer cells via JAK2/STAT3 pathway.
Cao L, Ren Y, Guo X, Wang L, Zhang Q, Li X, Wu X, Meng Z, Xu K. | 02/6/2021 |
| KMT Set7/9 is a new regulator of Sam68 STAR-protein. | KMT Set7/9 is a new regulator of Sam68 STAR-protein.
Vasileva E, Shuvalov O, Petukhov A, Fedorova O, Daks A, Nader R, Barlev N. | 01/2/2021 |